A Locke Lord team led by Chris Graham, Jen Lisi and Nicole Chakraborty (all of Providence) represented Nabsys 2.0, a developer and manufacturer of instrumentation and consumables for the analysis of genomic structural variation, in the acquisition of a majority interest in Nabsys by Hitachi High-Tech Corporation. Hitachi High-Tech, headquartered in Tokyo, Japan, is engaged in activities in a broad range of fields, including manufacture and sales of clinical analyzers, biotechnology products, radiation therapy systems, semiconductor manufacturing equipment, analytical instruments and analysis equipment. In addition to strengthening Nabsys’ development and production, Hitachi High-Tech will combine the Nabsys platform with its data analysis technology to scale and expand electronic genome mapping globally. For more information, see the press release. Additional assistance was provided by Peter Wynacht (Chicago), Jerry Francese, Ryan Last (both of New York), AJ Febles (Boston) and Adam Millard (Providence).
Posted on August 1, 2024